Sickle Cell Tests

There are almost 900 hemoglobin variants of which hemoglobin S is one. To screen for and to confirm the presence of hemoglobin S, a variety of tests have been developed. Some of these may include:

For Screening:
Screening may be performed on family members of an individual who has proven to have sickle cell trait/disease. It also may be done for those who were not screened at birth because universal testing was not yet implemented and who may choose to be tested if their status is not known.

• Hemoglobin S solubility test and Sodium Metabisulfite Test. Both tests are used in screening for hemoglobin S by adding certain chemicals to the patient's blood sample that reduce the amount of oxygen present. In those who carry one sickle cell gene (sickle cell trait), some hemoglobin S will be present. The reduced amount of oxygen will cause the abnormal sickle cells to form. This test detects the presence of hemoglobin S but does not distinguish between sickle cell disease and trait. It should not be performed on infants until they are at least 6 months old because of the presence of hemoglobin F at birth. Infants with sickle cell disease or trait will not produce significant amounts of hemoglobin S until several months after birth; thus this test may give a false negative result if performed too early (if hemoglobin S is <10%).

For Screening, Diagnosis, and Confirmation:

• Hemoglobinopathy (Hb) evaluation. There are several methods of evaluating the type and relative amounts of various normal and abnormal hemoglobin types. These methods typically separate the different types of hemoglobin that are present so that they can be identified and quantified. They include:
  • Hemoglobin electrophoresis has been traditionally used as the method to identify the presence of various hemoglobins.
  • Hemoglobin fractionation by HPLC is the most often used method for screening for hemoglobin variants, including Hb S.
  • Isoelectric focusing is also a highly sensitive method that is often used.
• Newborn screening for sickle cell is now mandated by all 50 states in the U.S. and the District of Columbia. It is performed via the more sensitive Hb isoelectric focusing or HPLC fractionation and identifies the specific types of hemoglobin present. As an infant with sickle cell trait/disease grows and develops, the amount of Hb S will increase as the amount of hemoglobin F decreases. At about age 2, the levels stabilize.
• DNA analysis. This test is used to investigate alterations and mutations in the genes that produce hemoglobin components. It may be performed to determine whether someone has one or two copies of the Hb S mutation or has two different gene mutations. Genetic testing is most often used for prenatal testing: amniotic fluid may be tested at 14 to 16 weeks to provide a definitive answer. Genetic counseling is strongly encouraged if a positive sickle screen from one or both parents is determined. It can also be performed earlier with chorionic villus sampling.

For monitoring treatment:
Particularly in patients with sickle cell disease, the amount of Hb S will be measured and followed over the course of a treatment, for example, after a blood transfusion to ensure that the hemoglobin S level has been reduced.

Other tests that may be used to help evaluate someone who is suspected of having or who is known to have sickle cell trait or disease include:

• Complete blood count (CBC). The CBC is a snapshot of the number of cells in the bloodstream. Among other things, the CBC will tell the doctor how many red blood cells are present and how much hemoglobin is in them, and will evaluate the size and shape of the red blood cells present. This test is used to detect anemia.
• Blood smear (also called peripheral smear and manual differential). In this test, a trained laboratorian looks at a thin stained layer of blood on a slide under a microscope. The number and type red blood cells are evaluated to see if they are normal. Sickled cells and cell fragments can be seen on the blood smear.
• Iron studies. These may include: iron, ferritin, UIBC, TIBC, and transferrin saturation. These tests measure different aspects of the body's iron storage and usage. They are ordered to help determine whether the patient has an iron deficiency anemia or an excess amount of iron. People with sickle cell anemia who receive multiple blood transfusions may experience an iron overload.

Testing may be done when those who were born before newborn screening was mandated want to know if they have sickle cell disease or are carrying the sickle cell trait, especially if they are in a high-risk group. It has been estimated that 1 out of every 500 African-Americans has sickle cell anemia.

One or more sickle cell tests may be done to help diagnose someone who has not previously been tested when they have symptoms and/or complications of the disease such as:

• Pain due to sickle cell crises - the most common symptoms of sickle cell disease are episodes of pain that can last for extended periods of time. The pain can occur throughout the body and often involves the bones, joints, lungs, and stomach.
• Anemia - sickle cell disease is a hemolytic anemia, meaning that the abnormal, sickled RBCs break down (hemolyze) more quickly than normal red blood cells and can not be replaced by the body as quickly as needed, thus leading to a decreased number of RBCs and reduced ability of the RBCs to transport oxygen throughout the body.
• Increased number and frequency of infections, especially pneumonia in children.
• Coughing, chest pain, and fever suspected to be caused by a serious complication of sickle cell disease called acute chest syndrome.

Diagnostic testing
Adults with sickle cell trait will produce mostly normal hemoglobin A, while those with sickle cell disease (anemia) will produce mostly Hb S with little or no Hb A. People who are heterozygous for two different hemoglobin variants will usually produce varying amounts of both types. For example, they may produce both Hb S and Hb C.

Genetic testing
If two copies of the Hb S gene mutation are detected, then the person has sickle cell disease. If they have one gene that codes for Hb S and one normal gene, then they have sickle cell trait. If they have one Hb S copy and a Hb C or beta thalassemia mutation, then they are likely to experience some symptoms and complications associated with sickle cell disease. If they have one Hb S gene copy and another, rarer hemoglobin variant, then they may or may not have any symptoms or complications. See the article on Hemoglobin Variants for more on this.

Recent blood transfusions may affect results.

People with sickle cell trait are generally healthy, but those who exercise heavily, such as athletes and those who are exposed to dehydration or altitude extremes, may sometimes experience sickle cell anemia symptoms. Sickle cell carriers produce both Hb A and some Hb S. When they are subjected to significant stresses that produce reduced oxygen in the body, the RBCs that contain Hb S can sickle.